Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
about
Improving care and wellness in bipolar disorder: origins, evolution and future directions of a collaborative knowledge exchange networkOxcarbazepine in the maintenance treatment of bipolar disorderQuetiapine monotherapy for bipolar depressionThe role of lamotrigine in the management of bipolar disorderThe long-term impact of treatment with electroconvulsive therapy on discrete memory systems in patients with bipolar disorderUnmet needs of bipolar disorder patientsMobile Apps for Bipolar Disorder: A Systematic Review of Features and Content QualityClinical practice guidelines in psychiatry: more confusion than clarity? A critical review and recommendation of a unified guidelineCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmThe International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelinesAssociation between duration of untreated bipolar disorder and clinical outcome: data from a Brazilian sample.Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.Structural brain changes in first episode mania with and without psychosis: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project.Medicating mood with maintenance in mind: bipolar depression pharmacotherapy.Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder.Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns.The psychopathology and treatment of bipolar disorder.A comparison of recommendations and received treatment for mood and anxiety disorders in a representative national sample.Pharmacovigilance for psychiatrists: An introductionTelomere Length, Oxidative Stress, Inflammation and BDNF Levels in Siblings of Patients with Bipolar Disorder: Implications for Accelerated Cellular Aging.Differentiating bipolar disorder from unipolar depression and ADHD: the utility of the general behavior inventory.Barriers to mental health treatment: results from the WHO World Mental Health surveys.Evaluation of guideline-concordant care for bipolar disorder among privately insured youthA review of bipolar disorder in adults.Valproate in acute mania: is our practice evidence based?Mania: diagnosis and treatment recommendations.A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.Potential mechanisms of action of lithium in bipolar disorder. Current understanding.The essential and potentially inappropriate use of antipsychotics across income groups: an analysis of linked administrative data.A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.Clinical practice recommendations for bipolar disorder.How well do psychosocial interventions work in bipolar disorder?Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) ReportObsessive-compulsive spectrum disorders: a review of the evidence-based treatments.Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions.The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.Korean Medication Algorithm Project for Bipolar Disorder: third revision.Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities
P2860
Q21202074-15A1813A-FD80-47EB-892F-60AC2E9846B7Q24242185-EA673DEC-D497-4022-A8F1-6B9A47230BF8Q24644541-5BFE7B81-C15E-4DBF-A006-8AADC83D66D8Q24658110-7D35EAB4-67CB-4F53-88AE-C5B93A244326Q24678893-D9ECDCE9-2CAD-4A0B-AE2F-AF0CC85E3908Q26738513-83AF83CD-6927-40CD-BC42-A69521538604Q26797449-E598116C-ECD0-4F05-B32B-C23DD5851204Q26830411-4D88E2C0-21C3-4697-BF52-2FF7EC463362Q27009995-6BFC86E0-456C-431B-9589-9D9252DBE650Q28066714-F7155E2F-F5F7-45DF-8A14-CCF4C6CB0B44Q28069743-36A2A11D-F802-48C6-9308-80F247A84460Q31037971-F939D581-6D9D-47D1-B509-2A9FE8715567Q31127921-81DE9A50-4E63-4A92-9905-61B644F59FD0Q31137985-2918662F-75BC-49AE-8930-C08790CE483FQ33414015-5A1E8A94-3B54-435F-AD20-66EA3875691CQ33470676-C6737471-84B2-42DD-A5ED-78384A6515B7Q33601890-BFD896E8-46A9-424A-869D-EE6F566205F4Q33606886-E21E2840-6BDC-4656-9C47-35FD1CFA1349Q33619910-D2C38FA4-7903-48A9-9869-6A38F30409A1Q33630005-A3518CBC-5111-4F85-A754-8B1ECD860B13Q33692129-6E00C772-6746-436A-8BB4-BD47F92D0CE3Q33762378-460203D2-1AC7-4253-8778-320D06086255Q33908484-35BCEC7D-F15C-4557-8EB3-CCD05DE42B56Q33908978-BFCE3CC3-F319-4C21-BB4B-541E72006A1BQ34163683-99822194-5A63-48AA-BC03-D7A108FDB3B7Q34237178-4C160A69-D241-476C-BD3E-6EB955A4F833Q34264093-89363FE2-51D6-424F-A0EB-38A2D2B43CCEQ34300315-0BB37AC4-DC01-48D0-84B2-7309D07D8B56Q34308807-30883A3A-530D-4F4A-B535-35E24D13458BQ34325612-75638A28-BDD6-4A96-B593-749F7D72F462Q34362036-A166724B-87D2-4918-84AE-FE89D7490636Q34595181-D092DE08-D2FF-4F9C-8316-1069C8E79AADQ34606360-62C5A294-33CD-4622-ABCE-EA4AAD60432CQ34620587-4354FC01-716E-4B84-BB2D-7EB2543E1E42Q34804607-3CFBFCB9-5A31-4E8A-B16B-7AB03119F650Q34984955-DC3BC391-86CB-427E-BA4C-63299F148DBAQ34987684-50D5A3E1-4DE6-4596-86EE-BCDE16DD09ACQ34998063-B1722BD8-04DC-4EF9-9035-9A7F8CF287ADQ35142737-0957FAF8-558B-4E44-80C4-DDC9D74612BDQ35236970-7B113B30-730D-4C81-8BBE-6100DBDD20A5
P2860
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Canadian Network for Mood and ...... : consensus and controversies.
@ast
Canadian Network for Mood and ...... : consensus and controversies.
@en
type
label
Canadian Network for Mood and ...... : consensus and controversies.
@ast
Canadian Network for Mood and ...... : consensus and controversies.
@en
prefLabel
Canadian Network for Mood and ...... : consensus and controversies.
@ast
Canadian Network for Mood and ...... : consensus and controversies.
@en
P2093
P2860
P1433
P1476
Canadian Network for Mood and ...... : consensus and controversies.
@en
P2093
Andree Daigneault
Arun Ravindran
Ayal Schaffer
Canadian Network for Mood and Anxiety Treatments
Chris P Gorman
Claire O'Donovan
Glenda MacQueen
L Trevor Young
Lakshmi N Yatham
Martin Alda
P2860
P356
10.1111/J.1399-5618.2005.00219.X
P478
P50
P577
2005-01-01T00:00:00Z